Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

mRNA-1273 vaccine effectiveness against symptomatic SARS-CoV-2 infection and COVID-19-related hospitalization in children aged 6 months to 5 years

Mary Aglipay, View ORCID ProfileJonathon Maguire, Sarah Swayze, View ORCID ProfileAshleigh Tuite, View ORCID ProfileMuhammad Mamdani, View ORCID ProfileCharles Keown-Stoneman, View ORCID ProfileCatherine Birken, View ORCID ProfileJeffrey C Kwong
doi: https://doi.org/10.1101/2023.06.27.23291933
Mary Aglipay
1Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
2Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Unity Health Toronto, Toronto, Ontario, Canada
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathon Maguire
2Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Unity Health Toronto, Toronto, Ontario, Canada
3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
4Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
5Department of Pediatrics, St Michael’s Hospital, Unity Health Toronto, Toronto, Ontario, Canada
MD MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jonathon Maguire
Sarah Swayze
6ICES, Toronto, Ontario, Canada
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashleigh Tuite
1Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ashleigh Tuite
Muhammad Mamdani
2Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Unity Health Toronto, Toronto, Ontario, Canada
3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
6ICES, Toronto, Ontario, Canada
7Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Muhammad Mamdani
Charles Keown-Stoneman
1Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
2Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Unity Health Toronto, Toronto, Ontario, Canada
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Charles Keown-Stoneman
Catherine Birken
3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
4Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
8Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada
9Division of Pediatric Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada
10Division of Paedatric Medicine, Hospital for Sick Children, Toronto, Ontario, Canada
MD MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Catherine Birken
Jeffrey C Kwong
1Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
6ICES, Toronto, Ontario, Canada
11Public Health Ontario, Toronto, Ontario, Canada
12Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada
13Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada
14University Health Network, Toronto, Ontario, Canada
MD MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jeffrey C Kwong
  • For correspondence: jeff.kwong{at}utoronto.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Importance Data on mRNA-1273 (Moderna) vaccine effectiveness in children aged 6 months to 5 years are limited.

Objective To assess mRNA-1273 vaccine effectiveness against symptomatic SARS-CoV-2 infection and COVID-19-related hospitalization among children aged 6 months to 5 years.

Design, Setting, and Participants A test-negative study using linked health administrative data in Ontario, Canada. Participants included symptomatic children aged 6 months to 5 years who were tested by RT-PCR.

Exposures mRNA-1273 vaccination.

Main Outcomes and Measures Symptomatic SARS-CoV-2 infection and COVID-19-related hospitalization.

Results We included 3467 test-negative controls and 572 test-positive cases. Receipt of mRNA-1273 was associated with reduced symptomatic SARS-CoV-2 infection (VE=90%; 95%CI: 53, 99%) and COVID-19-related hospitalization (VE=82%; 95%CI: 4, 99%) ≥7 days after the second dose.

Conclusions and Relevance Our findings suggest mRNA-1273 vaccine effectiveness is initially strong against symptomatic SARS-CoV-2 infection and hospitalization in children aged 6 months to 5 years. Further research is needed to understand long-term effectiveness and the need for booster doses.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health (MOH) and the Ministry of Long-Term Care (MLTC). This study also received funding from: the COVID-19 Immunity Task Force, a Province of Ontario initiative to support Ontario's ongoing response to COVID-19 and its related impacts and the Dalla Lana School of Public Health Data Science for Population Health Seed Grant. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by the OHDP, its partners, or the Province of Ontario is intended or should be inferred. Funders had no role in the design or conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. JCK is supported by a Clinician-Scientist Award from the University of Toronto Department of Family and Community Medicine. JM is supported by a Lawson Chair in Patient Engagement in Child Nutrition at the University of Toronto. CB is supported by the Edwin S.H. Leong Chair in Child Health Intervention at the University of Toronto. MM has received honoraria from Boehringer Ingelheim, Pfizer, Bristol-Myers Squibb, and Bayer. MA is supported by a trainee grant from CIHR and the Unity Health Toronto Research Training Centre.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

ICES is a prescribed entity under Ontario's Personal Health Information Protection Act (PHIPA). Section 45 of PHIPA authorizes ICES to collect personal health information, without consent, for the purpose of analysis or compiling statistical information with respect to the management of, evaluation or monitoring of, the allocation of resources to or planning for all or part of the health system. Projects that use data collected by ICES under section 45 of PHIPA, and use no other data, are exempt from REB review. The use of the data in this project is authorized under section 45 and approved by ICES' Privacy and Legal Office.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

The dataset from this study is held securely in coded form at ICES. While legal data sharing agreements between ICES and data providers (e.g., healthcare organizations and government) prohibit ICES from making the dataset publicly available, access may be granted to those who meet pre-specified criteria for confidential access, available at https://www.ices.on.ca/DAS (email: das{at}ices.on.ca).

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 28, 2023.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
mRNA-1273 vaccine effectiveness against symptomatic SARS-CoV-2 infection and COVID-19-related hospitalization in children aged 6 months to 5 years
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
mRNA-1273 vaccine effectiveness against symptomatic SARS-CoV-2 infection and COVID-19-related hospitalization in children aged 6 months to 5 years
Mary Aglipay, Jonathon Maguire, Sarah Swayze, Ashleigh Tuite, Muhammad Mamdani, Charles Keown-Stoneman, Catherine Birken, Jeffrey C Kwong
medRxiv 2023.06.27.23291933; doi: https://doi.org/10.1101/2023.06.27.23291933
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
mRNA-1273 vaccine effectiveness against symptomatic SARS-CoV-2 infection and COVID-19-related hospitalization in children aged 6 months to 5 years
Mary Aglipay, Jonathon Maguire, Sarah Swayze, Ashleigh Tuite, Muhammad Mamdani, Charles Keown-Stoneman, Catherine Birken, Jeffrey C Kwong
medRxiv 2023.06.27.23291933; doi: https://doi.org/10.1101/2023.06.27.23291933

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3292)
  • Dentistry and Oral Medicine (364)
  • Dermatology (279)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1171)
  • Epidemiology (13374)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5153)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3268)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1190)
  • Hematology (431)
  • HIV/AIDS (1017)
  • Infectious Diseases (except HIV/AIDS) (14627)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (477)
  • Medical Ethics (127)
  • Nephrology (523)
  • Neurology (4925)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (724)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (550)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4212)
  • Public and Global Health (7504)
  • Radiology and Imaging (1705)
  • Rehabilitation Medicine and Physical Therapy (1013)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (497)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)